June 23, 2022
Yasunori Yoshida (right), Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW A key health ministry panel on June 22 put a hold on its decision on whether to grant what could be the first emergency approval in...read more